Table 1.
High-risk Crohn’s disease | Low-risk Crohn’s disease | |
---|---|---|
Structural Damage | • Large or deep mucosal lesions • Fistula and/or perianal abscess • Prior intestinal resections, particularly of segments >40cm • Presence of strictures |
• Aphthous or small superficial ulcers • Absence of fistulae, abscess or strictures • No prior intestinal surgeries |
Inflammatory burden | • Extensive disease (ileal involvement >40cm or pancolitis) • Elevated C-reactive protein • Low albumin |
• Limited anatomic involvement • Normal C-reactive protein • Normal albumin |
Impact on quality of life | • Presence of stoma • >10 loose stools/week • Lack of symptomatic improvement with prior exposure to biologics and/or immunosuppressive agents • Significant impact of disease on activities of daily living • Presence of anorectal symptoms (anorectal pain, bowel urgency, incontinence, discharge, tenesmus) • Anemia • Daily abdominal pain • Corticosteroid use within last 1 year |
• Modest impact of disease on daily activities • No prior exposure to biologics and/or immunosuppressive agents • No prior disease-related hospitalization within the last 1 year • Absent to mildly active symptoms |
Emerging predictors | • High number and titer of anti-microbial antibodies • Antimicrobial genetic peptide signature |
- |